Enzo Biochem (NYSE:ENZ) Posts Earnings Results

Enzo Biochem (NYSE:ENZ) announced its earnings results on Monday. The medical research company reported ($0.05) earnings per share for the quarter, Zacks reports. Enzo Biochem had a negative return on equity of 11.84% and a negative net margin of 81.73%.

Enzo Biochem Trading Down 0.5 %

Shares of Enzo Biochem stock opened at $1.02 on Tuesday. Enzo Biochem has a 52-week low of $0.93 and a 52-week high of $1.50. The company’s 50-day simple moving average is $1.09 and its 200-day simple moving average is $1.11.

Enzo Biochem Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, December 2nd. Stockholders of record on Friday, November 15th were paid a $0.10 dividend. This represents a $0.40 annualized dividend and a dividend yield of 39.41%. The ex-dividend date of this dividend was Friday, November 15th.

Analyst Ratings Changes

Separately, StockNews.com began coverage on Enzo Biochem in a research report on Tuesday. They set a “hold” rating for the company.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.